Prosecution Insights
Last updated: October 02, 2026

Examiner: BECCIA, CHRISTOPHER J

Tech Center 3700 • Art Units: 2188 3775

This examiner grants 84% of resolved cases

Analysis

Christopher J. Beccia examines applications in Art Unit 2188 within Tech Center 3700. He has reached a final resolution in 1464 cases, establishing a very robust historical record for analysis. The allowance rate pct of 83.5 is high, indicating that the vast majority of applications in this portfolio result in a patent grant. This 83.5 percent rate suggests a very favorable environment for applicants seeking to secure intellectual property rights. The median days to allowance is 1025, reflecting a prosecution timeline that typically involves a significant duration of examination. This 1025-day median indicates that while success is highly probable, it requires a patient and steady approach over a lengthy period in Tech Center 3700. The volume of 1464 resolved cases provides high confidence in these metrics.

The interview lift pct of 14.0 shows that direct communication with the examiner is a productive strategy. This positive lift indicates that applications involving an interview are more likely to result in an allowance than those that rely solely on written prosecution. For practitioners, the 14.0 percent lift offers a clear path to further improving the already strong 83.5 percent baseline probability of success. Utilizing an interview can help resolve technical disagreements and potentially move the application toward a grant more effectively. In Art Unit 2188, the data suggests that a combination of strong written responses and strategic verbal negotiation is effective. Applicants should consider the interview as a key tool for navigating the 1025-day median wait time and securing a favorable outcome. The consistent performance across a large volume of cases suggests a predictable environment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

83.5%
Allow Rate
+13.5% vs TC avg
1,489
Total Applications
+14.0%
Interview Lift
1025
Avg Prosecution Days
Based on 1464 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
19.5%
§102 Novelty
57.7%
§103 Obviousness
7.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19255067 System And Method For Monitoring Offset During Navigation-Assisted Surgery Non-Final OA Stryker Corporation
18948005 METHOD AND APPARATUS FOR ACCESSING THE INTERIOR OF A HIP JOINT, INCLUDING THE PROVISION AND USE OF A NOVEL TELESCOPING ACCESS CANNULA AND A NOVEL TELESCOPING OBTURATOR Non-Final OA Stryker Corporation
19072333 Partially Resorbable Implants And Methods Non-Final OA Stryker European Operations Holdings LLC
19024558 Implant for Bone Fixation Non-Final OA Stryker European Operations Holdings LLC
18535246 Robotic Cement Pressurizer Final Rejection Howmedica Osteonics Corp.
19032828 Techniques For Patient-Specific Milling Path Generation Non-Final OA MAKO Surgical Corp.
19299985 EXPANDABLE SPINAL IMPLANT SYSTEM AND METHOD OF USING SAME Non-Final OA Warsaw Orthopedic, Inc.
19259599 SPINAL IMPLANT SYSTEM AND METHOD Non-Final OA Warsaw Orthopedic, Inc.
18915702 FEMORAL OFFSET SYSTEM FOR KNEE ARTHROPLASTY PROCEDURE Final Rejection Aesculap AG
18843794 ORTHOPEDIC IMPLANT ASSEMBLY FOR PROXIMAL FEMUR REPLACEMENT Non-Final OA Smith & Nephew Asia Pacific PTE. Limited
18669233 OSTEOTOME WITH INFLATABLE PORTION AND MULTIWIRE ARTICULATION Non-Final OA Merit Medical Systems, Inc.
18780198 GUIDE DEVICE Final Rejection National University Corporation Tokyo Medical and Dental University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month